ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/L-Fmoc-Aspartic acid alpha-tert-butyl ester
C23H25NO6
411.4 g/mol
Pharmaceutical IntermediateWarning

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoic acid

CAS129460-09-9EC675-834-7
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

N-(fluorenylmethoxycarbonyl)-L-aspartic acid tert-butyl ester is a protected derivative of aspartic acid, commonly used as a building block in peptide synthesis. Its Fmoc (fluorenylmethoxycarbonyl) and tert-butyl ester groups allow selective deprotection during solid-phase peptide assembly.

intermediate in solid-phase peptide synthesisbuilding block for Fmoc-based peptide chemistryreagent for research in pharmaceutical intermediate manufacturing

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.80

Fmoc-L-Glutamic acid 1-tert-butyl ester

CAS84793-07-7

pharmaceutical intermediate

SimilarStructure SimilarSimilarity 0.80

N-(9-Fluorenylmethyloxycarbonyl)-D-glutamic acid 1-tert-butyl ester

CAS109745-15-5

research compound

SimilarStructure SimilarSimilarity 0.79

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-aspartic acid 1-methyl ester

CAS145038-52-4

pharmaceutical intermediate

SimilarStructure SimilarSimilarity 0.75

Fmoc-D-Aspartic acid beta-tert-butyl ester

CAS112883-39-3

pharmaceutical intermediate

ReferenceSame Category

1-((3-Aminoquinolin-4-yl)amino)-2-methylpropan-2-ol

CAS129655-59-0

pharmaceutical intermediate

ReferenceSame Category

3,4-Dihydro-7-(4-bromobutoxy)-2(1H)-quinolinone

CAS129722-34-5

pharmaceutical intermediate

ReferenceSame Category

2-chloro-4-(1H-pyrazol-5-yl)benzonitrile

CAS1297537-37-1

pharmaceutical intermediate

ReferenceSame Category

(S)-4-(1-(2-aminopropyl)-1H-pyrazol-3-yl)-2-chlorobenzonitrile

CAS1297537-41-7

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Harmful
Harmful
Warning
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
Identifiers
IUPAC Name

(3S)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid

InChIKey

VZXQYACYLGRQJU-IBGZPJMESA-N

SMILES

CC(C)(C)OC(=O)[C@H](CC(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

Synonyms (18)
  • Fmoc-Asp(OH)-OtBu
  • Fmoc-L-Asp-OtBu
  • fmoc-asp-otbu

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→